Spectrum and Risk of Neoplasia in Werner Syndrome: A Systematic Review

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Lauper, Julia M ^a   Krause, Alison ^a   Vaughan, Thomas L ^a,b   Monnat, Raymond J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DETERMINATION; AGE DISTRIBUTION; AGED; ARTICLE; BONE CANCER; BONE MARROW CANCER; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAPAN; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MELANOMA; MENINGIOMA; PRELEUKEMIA; PRIMARY TUMOR; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SOFT TISSUE SARCOMA; STANDARDIZED INCIDENCE RATIO; STANDARDIZED PROPORTIONATE INCIDENCE RATIO; SYSTEMATIC REVIEW; THYROID TUMOR; TISSUE CHARACTERIZATION; WERNER SYNDROME;

EID: 84875673276     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059709     Document Type: Article

References (35)

1. Epstein CJ, Martin GM, Schultz AL, Motulsky AG, (1966) Werner's syndrome: A review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process. Medicine (Baltimore) 45: 177-221.
2. Goto M, (1997) Hierarchical deterioration of body systems in Werner's syndrome: implications for normal ageing. Mech Ageing Dev 98: 239-254.
3. Huang S, Lee L, Hanson NB, Lenaerts C, Hoehn H, et al. (2006) The spectrum of WRN mutations in Werner syndrome patients. Hum Mutat 27: 558-567.
4. Monnat RJ Jr (2001) Cancer pathogenesis in the human RecQ helicase deficiency syndromes. In: Goto M, Miller RW, editors. From Premature Gray Hair to Helicase- Werner Syndrome: Implications for Aging and Cancer. Tokyo: Japan Scientific Societies Press. pp. 83-94.
5. Goto M, Miller RW, Ishikawa Y, Sugano H, (1996) Excess of rare cancers in Werner syndrome (adult progeria). Cancer Epidemiol Biomarkers Prev 5: 239-246.
6. Monnat RJ Jr (2002) Werner syndrome. In: Fletcher C, Unni K, Mertens F, editors. WHO/IARC Monograph on Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: IARC Press. pp. 273-274.
7. Ferlay J, Parkin DM, Curado MP, Bray F, Edwards B, et al. (2010) Cancer Incidence in Five Continents, Volumes I to IX website. Lyon, France: International Agency for Research on Cancer. Available: http://ci5.iarc.fr. Accessed 2012 Jun 19.
8. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, et al. (2000) International Classification of Diseases for Oncology. 3rd ed. Geneva: World Health Organization.
9. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J, editors (1997) Cancer Incidence in Five Continents, Vol. VII. Lyon: IARC.
10. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, editors (2002) Cancer Incidence in Five Continents, Vol. VIII. Lyon: IARC.
11. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, et al. (2007) Cancer Incidence in Five Continents, Vol. IX. Lyon: IARC.
12. Satoh M, Imai M, Sugimoto M, Goto M, Furuichi Y, (1999) Prevalence of Werner's syndrome heterozygotes in Japan. Lancet 353: 1766.
13. Schellenberg GD, Miki T, Yu CE, Nakura J (2001) Werner syndrome. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE et al., editors. Online Metabolic and Molecular Basis of Inherited Disease. New York: McGraw-Hill. pp. 1-36.
14. Ishikawa Y, Miller RW, Machinami R, Sugano H, Goto M, (2000) Atypical osteosarcomas in Werner Syndrome (adult progeria). Jpn J Cancer Res 91: 1345-1349.
15. Monnat RJ Jr, (1999) Unusual features of thyroid carcinomas in Japanese patients with Werner syndrome and possible genotype-phenotype relations to cell type and race. Cancer 86: 728-729.
16. Monnat RJ Jr, (2010) Human RECQ helicases: roles in DNA metabolism, mutagenesis and cancer biology. Semin Cancer Biol 20: 329-339.
17. Fukuchi K, Tanaka K, Kumahara Y, Marumo K, Pride MB, et al. (1990) Increased frequency of 6-thioguanine-resistant peripheral blood lymphocytes in Werner syndrome patients. Hum Genet 84: 249-252.
18. Kyoizumi S, Kusunoki Y, Seyama T, Hatamochi A, Goto M, (1998) In vivo somatic mutations in Werner's syndrome. Hum Genet 103: 405-410.
19. Moser MJ, Bigbee WL, Grant SG, Emond MJ, Langlois RG, et al. (2000) Genetic instability and hematologic disease risk in Werner syndrome patients and heterozygotes. Cancer Res 60: 2492-2496.
20. Monnat RJ Jr (2006) Werner syndrome as a model of human aging. In: Conn PM, editor. Handbook of Models for Human Aging. Amsterdam: Elsevier Academic Press. pp. 961-976.
21. Seiter K, Qureshi A, Liu D, Galvin-Parton P, Arshad M, et al. (2005) Severe toxicity following induction chemotherapy for acute myelogenous leukemia in a patient with Werner's syndrome. Leuk Lymphoma 46: 1091-1095.
22. Feinberg AP, Coffey DS, (1982) Organ site specificity for cancer in chromosomal instability disorders. Cancer Res 42: 3252-3254.
23. German J, (1997) Bloom's syndrome: XX. The first 100 cancers. Cytogenet Cell Genet 93: 100-106.
24. Wang LL, Gannavarapu A, Kozinetz CA, Levy ML, Lewis RA, et al. (2003) Association between osteosarcoma and deleterious mutations in the RECQL4 gene in Rothmund-Thomson syndrome. J Natl Cancer Inst 95: 669-674.
25. Siitonen HA, Sotkasiira J, Biervliet M, Benmansour A, Capri Y, et al. (2009) The mutation spectrum in RECQL4 diseases. Eur J Hum Genet 17: 151-158.
26. Birch JM, Blair V, Kelsey AM, Evans DG, Harris M, et al. (1998) Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome. Oncogene 17: 1061-1068.
27. Birch JM, Alston RD, McNally RJ, Evans DG, Kelsey AM, et al. (2001) Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene 20: 4621-4628.
28. Alter BP, (2003) Cancer in Fanconi anemia, 1927-2001. Cancer 97: 425-440.
29. Rosenberg PS, Greene MH, Alter BP, (2003) Cancer incidence in persons with Fanconi anemia. Blood 101: 822-826.
30. Alter BP, Giri N, Savage SA, Rosenberg PS, (2009) Cancer in dyskeratosis congenita. Blood 113: 6549-6557.
31. Vlachos A, Rosenberg PS, Atsidaftos E, Alter BP, Lipton JM, (2012) Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry. Blood 119: 3815-3819.
32. Dror Y, (2008) Shwachman-Diamond syndrome: implications for understanding the molecular basis of leukaemia. Expert Rev Mol Med 10: e38.
33. Huang J, Shimamura A, (2011) Clinical spectrum and molecular pathophysiology of Shwachman-Diamond syndrome. Curr Opin Hematol 18: 30-35.
34. De Vos M, Hayward BE, Charlton R, Taylor GR, Glaser AW, et al. (2006) PMS2 mutations in childhood cancer. J Natl Cancer Inst 98: 358-361.
35. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, et al. (2012) SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). Bethesda, MD: National Cancer Institute. http://seer.cancer.gov/csr/1975_2009_pops09/. Accessed 26 February 2013.